Welcome to Medications.com
 

Eisai/Pfizer's Aricept Owns a Dominating 42.4% Patient Share for ... - FOXBusiness

The new report entitled Treatment Algorithms in Alzheimer's Disease finds that the reasons for favoring Aricept differ between primary care physicians and ...

Posted: Mon Feb 04 16:51:33 +0000 2008


© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea